JPS37225B1 - - Google Patents

Info

Publication number
JPS37225B1
JPS37225B1 JP2067858A JP2067858A JPS37225B1 JP S37225 B1 JPS37225 B1 JP S37225B1 JP 2067858 A JP2067858 A JP 2067858A JP 2067858 A JP2067858 A JP 2067858A JP S37225 B1 JPS37225 B1 JP S37225B1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2067858A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP2067858A priority Critical patent/JPS37225B1/ja
Publication of JPS37225B1 publication Critical patent/JPS37225B1/ja
Pending legal-status Critical Current

Links

JP2067858A 1958-07-23 1958-07-23 Pending JPS37225B1 (hr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2067858A JPS37225B1 (hr) 1958-07-23 1958-07-23

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2067858A JPS37225B1 (hr) 1958-07-23 1958-07-23

Publications (1)

Publication Number Publication Date
JPS37225B1 true JPS37225B1 (hr) 1962-01-23

Family

ID=40429970

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2067858A Pending JPS37225B1 (hr) 1958-07-23 1958-07-23

Country Status (1)

Country Link
JP (1) JPS37225B1 (hr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1847263A3 (en) * 2000-12-18 2009-08-26 Institute of Medicinal Molecular Design, Inc. Inhibitors against the production and release of inflammatory cytokines
US7626042B2 (en) 2002-06-06 2009-12-01 Institute Of Medicinal Molecular Design, Inc. O-substituted hydroxyaryl derivatives
US7671058B2 (en) 2006-06-21 2010-03-02 Institute Of Medicinal Molecular Design, Inc. N-(3,4-disubstituted phenyl) salicylamide derivatives
US7700655B2 (en) 2002-06-06 2010-04-20 Institute Of Medicinal Molecular Design, Inc. Antiallergic agents

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1847263A3 (en) * 2000-12-18 2009-08-26 Institute of Medicinal Molecular Design, Inc. Inhibitors against the production and release of inflammatory cytokines
US8097759B2 (en) 2000-12-18 2012-01-17 Institute Of Medicinal Molecular Design, Inc. Inflammatory cytokine release inhibitor
US8263657B2 (en) 2000-12-18 2012-09-11 Institute Of Medicinal Molecular Design, Inc. Inhibitors against the production and release of inflammatory cytokines
US7626042B2 (en) 2002-06-06 2009-12-01 Institute Of Medicinal Molecular Design, Inc. O-substituted hydroxyaryl derivatives
US7700655B2 (en) 2002-06-06 2010-04-20 Institute Of Medicinal Molecular Design, Inc. Antiallergic agents
US7671058B2 (en) 2006-06-21 2010-03-02 Institute Of Medicinal Molecular Design, Inc. N-(3,4-disubstituted phenyl) salicylamide derivatives

Similar Documents

Publication Publication Date Title
JPS3618584B1 (hr)
FR1226211A (hr)
JPS37225B1 (hr)
AT221043B (hr)
AT217439B (hr)
JPS356847B1 (hr)
AT216831B (hr)
AT216749B (hr)
AT216771B (hr)
AT216803B (hr)
FR587M (hr)
AT213313B (hr)
AT217982B (hr)
AT219815B (hr)
AT219868B (hr)
DE1252412B (hr)
CS96704B5 (hr)
BE562122A (hr)
BE538749A (hr)
BE563683A (hr)
BE563346A (hr)
BE563272A (hr)
BE563232A (hr)
BE562866A (hr)
BE569532A (hr)